Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2026

Rhea-AI Summary

Kewaunee Scientific (NASDAQ: KEQU) announced it will release its second quarter fiscal year 2026 financial results on Wednesday, December 10, 2025 after the close of trading. The company said the release will be posted on its website and accompanying materials will be available at www.kewaunee.com.

The release reiterates company background: Kewaunee designs and manufactures laboratory and healthcare furniture, operates manufacturing sites in Statesville and Bangalore, and recently acquired subsidiary Nu Aire, a maker of biological safety cabinets and lab equipment. The notice includes customary forward-looking statements and risk factors and provides an investor contact.

News Market Reaction – KEQU

-2.96%

1 alert

-2.96% News Effect

On the day this news was published, KEQU declined 2.96%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Earnings release date: December 10, 2025 Company founded: 1906 Manufacturing facilities US: 3 facilities +2 more

5 metrics

Earnings release date December 10, 2025 Scheduled Q2 FY2026 financial results release

Company founded 1906 Year Kewaunee Scientific was founded

Manufacturing facilities US 3 facilities Statesville, North Carolina serving domestic and international markets

Manufacturing facilities India 1 facility Bangalore plant serving local, Asian, and African markets

Nu Aire founded 1971 Founding year of Nu Aire subsidiary

Market Reality Check

Price: $40.61 Vol: Volume 30,274 is about 3....

high vol

$40.61 Last Close

Volume Volume 30,274 is about 3.64x the 20-day average of 8,312, indicating elevated trading interest ahead of the scheduled results. high

Technical Shares at $38.26 are trading below the 200-day MA of $44.81, after a recent 3.15% daily gain.

Peers on Argus

KEQU gained 3.15% with elevated volume, while peers were mixed: VIRC +0.88%, BSE...

KEQU gained 3.15% with elevated volume, while peers were mixed: VIRC +0.88%, BSET +3.43%, HOFT +18.69%, NVFY -4.78%, PRPL +0.32%, pointing to stock-specific interest rather than a uniform sector move.

Historical Context

5 past events · Latest: Dec 10 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Dec 10	Earnings results	Positive	+3.1%	Strong Q2 FY2026 sales growth and backlog with Nu Aire contribution.
Dec 04	Debt refinancing	Positive	+1.3%	Refinancing and full repayment of Nu Aire seller notes lowering debt costs.
Nov 26	Earnings date notice	Neutral	-3.0%	Administrative notice of Q2 FY2026 earnings release timing.
Sep 11	Board appointment	Positive	-1.6%	Addition of experienced director J. Jette Campbell to board.
Sep 10	Earnings results	Positive	-21.2%	Strong Q1 FY2026 sales, earnings, and backlog growth including Nu Aire.

Pattern Detected

Operationally strong earnings and balance-sheet actions have not always been rewarded; one recent strong earnings release coincided with a double-digit decline, while debt refinancing and the latest quarter’s results saw modest gains.

Recent Company History

This announcement continues a sequence of earnings and strategic updates for Kewaunee Scientific. On Sep 10, 2025, the company reported strong Q1 FY2026 growth but the stock fell 21.23%. A board appointment on Sep 11, 2025 also saw a mild negative reaction. In contrast, debt refinancing and full repayment of Nu Aire seller notes on Dec 4, 2025 and strong Q2 FY2026 results on Dec 10, 2025 were followed by positive price moves, highlighting mixed market responses to otherwise constructive news.

Market Pulse Summary

This announcement sets the schedule for Kewaunee Scientific’s Q2 FY2026 results on December 10, 2025...

Analysis

This announcement sets the schedule for Kewaunee Scientific’s Q2 FY2026 results on December 10, 2025 and reiterates its expanded laboratory and healthcare furniture platform, including the Nu Aire acquisition. Historical news shows strong recent sales and backlog trends, along with balance sheet moves like debt refinancing. Investors may focus on how the upcoming report updates integration of Nu Aire, order backlog progression, and any commentary on demand volatility and global operating risks highlighted in the company’s risk disclosures.

Key Terms

biological safety cabinets, co2 incubators, ultralow freezers, forward-looking statements, +4 more

8 terms

biological safety cabinets medical

"Nu Aire, is a leading manufacturer of biological safety cabinets, CO2 incubators,"

An enclosed, ventilated workspace that keeps lab workers, the surrounding environment, and delicate biological samples separate by controlling airflow and filtering out contaminants—think of it as a clean, protective box that prevents germs and particles from spreading. Investors care because these cabinets are required for safe research, clinical testing and manufacturing; their presence affects a lab’s ability to operate legally and reliably, influencing regulatory risk, operating costs and the pace at which scientific work can be commercialized.

co2 incubators medical

"Nu Aire, is a leading manufacturer of biological safety cabinets, CO2 incubators, ultralow"

A CO2 incubator is a laboratory device that creates and maintains a stable, warm, humid environment with controlled carbon dioxide levels so living cells and tissues can be grown and studied, similar to a small, climate-controlled greenhouse for cells. Investors care because these machines are essential tools for biotech, pharmaceutical and medical-research work, creating steady demand, consumable sales and replacement cycles that can indicate strength or growth in the life-sciences equipment market.

ultralow freezers medical

"CO2 incubators, ultralow freezers, and other essential laboratory products"

Ultralow freezers are heavy-duty refrigeration units that keep samples and materials at extremely low temperatures (typically around -80°C), acting like a deep freezer built for delicate biological and chemical items such as vaccines, cells, and research reagents. Investors should care because these units are critical for labs, biotechs and cold-chain logistics: they represent capital spending, recurring energy and maintenance costs, and capacity constraints that can affect research throughput, product readiness and regulatory compliance.

forward-looking statements regulatory

"contains statements that the Company believes to be "forward-looking statements" within"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

form 10-k regulatory

"caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for"

A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.

form 10-q regulatory

"and in our subsequent quarterly reports on Form 10-Q and current reports"

A Form 10-Q is a detailed report that publicly traded companies are required to file with regulators three times a year, providing an update on their financial health and business activities. It is important for investors because it offers timely insights into a company's performance, helping them make informed decisions about buying or selling stocks. Think of it as a regular check-up report that shows how well a company is doing.

form 8-k regulatory

"our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K."

A Form 8-K is a report that companies file with the government to share important news quickly, such as changes in leadership, major business deals, or financial updates. It matters because it helps investors stay informed about significant events that could affect the company's value or stock price.

force majeure regulatory

"natural disasters and other Force Majeure events. The cautionary statements"

Force majeure is a legal concept that refers to unexpected events beyond anyone’s control, such as natural disasters, war, or severe disruptions, that prevent a party from fulfilling their obligations. It matters to investors because it can delay or cancel agreements, affecting the timing and certainty of financial transactions and obligations. Essentially, it acts as a shield for parties facing unforeseen, uncontrollable problems.

AI-generated analysis. Not financial advice.

STATESVILLE, N.C., Nov. 26, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its second quarter fiscal year 2026 financial results on Wednesday, December 10, 2025 after the close of trading. This information will be available on the Company's website www.kewaunee.com after the release.

About Kewaunee Scientific

Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The Company's corporate headquarters are located in Statesville, North Carolina. Sales offices are located in the United States, India, Saudi Arabia, and Singapore. Three manufacturing facilities are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets. 

Kewaunee Scientific's newly acquired subsidiary, Nu Aire, is a leading manufacturer of biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products that complement the Kewaunee Scientific portfolio. Founded in 1971, Nu Aire's headquarters and manufacturing facilities are located in Plymouth, Minnesota, with additional manufacturing capabilities located in Long Lake, Minnesota. The Company also maintains a warehouse partnership in the Netherlands and OEM partnerships in China.

Learn more at the companies' websites, located at http://www.kewaunee.com and http://www.nuaire.com/.  

This press release contains statements that the Company believes to be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this press release, including statements regarding the Company's future financial condition, results of operations, business operations and business prospects, are forward-looking statements. Words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "predict," "believe" and similar words, expressions and variations of these words and expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions, and other important factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. Such factors, risks, uncertainties and assumptions include, but are not limited to: our ability to realize the benefits anticipated as a result of the Nu Aire acquisition; competitive and general economic conditions, including disruptions from government mandates, both domestically and internationally, as well as supplier constraints and other supply disruptions; changes in customer demands; technological changes in our operations or in our industry; dependence on customers' required delivery schedules; risks related to fluctuations in the Company's operating results from quarter to quarter; risks related to international operations, including foreign currency fluctuations; changes in the legal and regulatory environment; changes in raw materials and commodity costs; acts of terrorism, war, governmental action, and natural disasters and other Force Majeure events. The cautionary statements made pursuant to the Reform Act herein and elsewhere by us should not be construed as exhaustive. We cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. Over time, our actual results, performance, or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by our forward-looking statements, and such difference might be significant and harmful to our stockholders' interest. Many important factors that could cause such a difference are described under the caption "Risk Factors," in Item 1A of our Annual Report on Form 10-K for the fiscal year ended April 30, 2025, which you should review carefully, and in our subsequent quarterly reports on Form 10-Q and current reports on Form 8-K. These reports are available on our investor relations website at www.kewaunee.com and on the SEC website at www.sec.gov. These forward-looking statements speak only as of the date of this document. The Company assumes no obligation, and expressly disclaims any obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:	Donald T. Gardner III
	704/871-3274

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/kewaunee-scientific-to-report-results-for-second-quarter-fiscal-year-2026-302626816.html

SOURCE Kewaunee Scientific Corporation

FAQ

When will Kewaunee Scientific (KEQU) report Q2 FY2026 results?

Kewaunee will release Q2 fiscal 2026 results on Wednesday, December 10, 2025 after the close of trading.

Where can investors find Kewaunee Scientific (KEQU) Q2 FY2026 results and materials?

The company said results and related materials will be available on its investor website at www.kewaunee.com after the release.

What businesses does Kewaunee Scientific (KEQU) operate and where are its manufacturing sites?

Kewaunee designs and manufactures laboratory and healthcare furniture with manufacturing in Statesville, North Carolina and Bangalore, India, plus sales offices in the US, India, Saudi Arabia, and Singapore.

How does the Nu Aire acquisition relate to Kewaunee Scientific (KEQU)?

Kewaunee described Nu Aire as a newly acquired subsidiary that manufactures biological safety cabinets, CO2 incubators, and ultralow freezers that complement its product portfolio.

Who is the investor contact for Kewaunee Scientific (KEQU) press inquiries?

The release lists Donald T. Gardner III with phone 704-871-3274 as the contact for investor inquiries.